12.31
+0.065(+0.53%)
Currency In USD
| Previous Close | 12.25 |
| Open | 12.27 |
| Day High | 12.33 |
| Day Low | 11.94 |
| 52-Week High | 21.95 |
| 52-Week Low | 4.5 |
| Volume | 15,456 |
| Average Volume | 50,044 |
| Market Cap | 49.78M |
| PE | -0.57 |
| EPS | -21.61 |
| Moving Average 50 Days | 9.96 |
| Moving Average 200 Days | 9.58 |
| Change | 0.07 |
If you invested $1000 in FibroGen, Inc. (FGEN) 10 years ago, it would be worth $22.73 as of September 29, 2025 at a share price of $12.31. Whereas If you bought $1000 worth of FibroGen, Inc. (FGEN) shares 5 years ago, it would be worth $11.83 as of September 29, 2025 at a share price of $12.31.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer
GlobeNewswire Inc.
Sep 24, 2025 11:00 AM GMT
FG-3246 Phase 2 dose optimization trial to enroll 75 patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-androgen receptor signaling inhibitor (ASRI) and pre-chemotherapy setting FG-3180 to be evaluated in the Phase 2 tr
FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million
GlobeNewswire Inc.
Sep 02, 2025 11:00 AM GMT
Total consideration for the sale of FibroGen China to AstraZeneca is approximately $220 million, a $60 million increase from initial guidanceSuccessfully repaid term loan to Morgan Stanley Tactical Value, further simplifying the Company’s capital str
FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Aug 27, 2025 8:02 PM GMT
SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025, in New